Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On September 8, 2022, Cardinal Health, Inc. (the "Company") announced that
Victor L. Crawford will cease to serve as Chief Executive Officer,
Pharmaceutical Segment effective September 19, 2022. Mr. Crawford will remain
with the Company through November 13, 2022 to help with the transition of the
role to his replacement. The Board of Directors of the Company has determined
that Mr. Crawford's departure from the Company will entitle him to severance
benefits as an involuntary termination without cause under the Cardinal Health,
Inc. Senior Executive Severance Plan (as amended, the "Severance Plan")
following his departure date. Receipt of these severance benefits is subject to
the terms of the Severance Plan, including the required execution of a general
release and compliance with certain restrictive covenants. The Severance Plan is
filed as Exhibits 10.7.1 and 10.7.2 to the Company's Annual Report on Form 10-K
filed with the U.S. Securities and Exchange Commission on August 11, 2022.
Item 7.01. Regulation FD
The Company issued a news release on September 8, 2022 announcing Pharmaceutical
segment organizational changes, which is being furnished as Exhibit 99.1 to this
Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 News release issued by the Company on September 8, 2022 announcing
Pharmaceutical segment organizational changes
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
CARDINAL HEALTH, INC. 
